MRK
Court Rejects Merck’s Challenge to Medicare Drug Price Negotiation Program
Court Rejects Merck’s Challenge to Medicare Drug Price Negotiation Program...
Financial News Archive
SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
MRK
Argus Research Maintains Buy on Merck & Co, Raises Price Target to $170
Argus Research Maintains Buy on Merck & Co, Raises Price Target to $170...
AAPL
Apple Introduces The M5 Ultra, Its Most Powerful Chip Ever, And M6, Its First 2nm Chip
Apple Introduces The M5 Ultra, Its Most Powerful Chip Ever, And M6, Its First 2nm Chip...
CRM
Citizens Reiterates Market Outperform on Salesforce, Maintains $315 Price Target
Citizens Reiterates Market Outperform on Salesforce, Maintains $315 Price Target...
MRNA
Moderna Stock Edges Higher Tuesday: What's Happening?
Moderna Stock Edges Higher Tuesday: What's Happening?...
NKE
RBC Capital Reiterates Sector Perform on Nike, Maintains $45 Price Target
RBC Capital Reiterates Sector Perform on Nike, Maintains $45 Price Target...
SMCI
What's Going On With Super Micro Computer Stock Tuesday?
What's Going On With Super Micro Computer Stock Tuesday?...
BE
Bloom Energy Stock Rises as Pelosi-Linked Trades Draw Fresh Attention
Bloom Energy Stock Rises as Pelosi-Linked Trades Draw Fresh Attention...
NKE
Nike shares are trading lower amid sympathy with Dick's Sporting Goods after the company reported worse-than-expected Q2 financial results and noted challenging athletic footwear and apparel markets.
Nike shares are trading lower amid sympathy with Dick's Sporting Goods after the company reported worse-than-expected Q2 financial results and noted c...
CSCO
Cisco Expands Rack-Scale AI Computing With Nvidia, Supermicro
Cisco Expands Rack-Scale AI Computing With Nvidia, Supermicro...
V
President Of Visa Makes $6.65M Sale
President Of Visa Makes $6.65M Sale...
DKS
Dick's Sporting Goods Stock Plunges 25% on $31.9M Foot Locker Investment Loss
Dick's Sporting Goods Stock Plunges 25% on $31.9M Foot Locker Investment Loss...
V
Wolfe Research Maintains Outperform on Visa, Raises Price Target to $460
Wolfe Research Maintains Outperform on Visa, Raises Price Target to $460...
MRK
Wolfe Research Maintains Outperform on Merck & Co, Raises Price Target to $180
Wolfe Research Maintains Outperform on Merck & Co, Raises Price Target to $180...
DELL
What's Going On With Dell Technologies Stock Tuesday?
What's Going On With Dell Technologies Stock Tuesday?...
CRM
Salesforce Q2: AI Is Growing Fast, CRM Needs New Customers To Catch Up
Salesforce Q2: AI Is Growing Fast, CRM Needs New Customers To Catch Up...
AMGN
Here’s How Much You Would Have Made Owning Amgen Stock In The Last 15 Years
Here’s How Much You Would Have Made Owning Amgen Stock In The Last 15 Years...
MRK
Live On CNBC, Josh Brown Host Segment Titled “Josh’s Best Stocks In The Market: Merck"
Live On CNBC, Josh Brown Host Segment Titled “Josh’s Best Stocks In The Market: Merck"...
MRK
Merck shares are trading higher after Argus Research and Wolfe Research raised their respective price targets on the stock.
Merck shares are trading higher after Argus Research and Wolfe Research raised their respective price targets on the stock....
TSLA
10 Consumer Discretionary Stocks Whale Activity In Today’s Session
10 Consumer Discretionary Stocks Whale Activity In Today’s Session...